Clinical Trial

Antibiotic Prophylaxis for EUS-FNA of Pancreatic Cystic Lesions

Study acronym: PrePaCyst
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Large prospective comparative observational study in numerous reference centers in France, comparing infectious complications in patients admitted for pancreatic cystic lesions (PCL) aspiration performed with or without antibiotic prophylaxis (ATBp) according to the usual practices. This is a prospective, comparative, observational, multicenter study, with the primary objective of comparing the infection rates in pancreatic cystic lesions (PCL) aspirated under EUS, with and without the administration of ATBp. A sample size of 1702 patients will be needed over a 3-year study period.
Trial Details
NCT Number NCT06535490
Lead Sponsor Société Française d'Endoscopie Digestive
Conditions Pancreatic Cystic Lesion
Enrollment 1,702 participants
Start Date 2024-09-15
Primary Completion 2027-09-15 (estimated)
Study Completion 2027-10-15 (estimated)
Updated on ClinicalTrials.gov 2024-08-02